HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brink, I. Articles by Nitzsche, E. U. Search for Related Content PubMed PubMed Citation Articles by Brink, I. Articles by Nitzsche, E. U.

Increased Metabolic Activity in the Thymus Gland Studied with ¹⁸F-FDG PET: Age Dependency and Frequency After Chemotherapy

Division of Nuclear Medicine and Department of Diagnostic Radiology, School of Medicine, Albert-Ludwigs University of Freiburg, Freiburg, Germany

This study was designed to evaluate the age dependency of ¹⁸F-FDG uptake in the thymus and the frequency of PET confirmation of thymus hyperplasia after chemotherapy in cancer patients. Methods: Whole-body FDG PET recordings of 168 patients were retrospectively examined for a retrosternal lesion in the anterior mediastinum that was attributable to the thymus. The patients were assigned to the following four groups: children with malignant lesions before the first therapy (group Ia; n = 15; mean age ± SD, 11.9 ± 3.7 y), children with malignant disease after chemotherapy (group Ib; n = 12; mean age, 10.3 ± 5.0 y), adults with histologically confirmed malignant lymphoma before the first therapy (group IIa; n = 37; mean age, 43.9 ± 16.7 y), and adult lymphoma patients 3 wk to 4 mo after chemotherapy (group IIb; n = 104; mean age, 40.9 ± 14.6 y). Results: Increased FDG accumulation in the thymus was seen in 11 patients (73%) of group Ia and 9 patients (75%) of group Ib. Thymus hyperplasia was found in 5 patients (5%) of group IIb. The eldest of these 5 patients was 25 y old. No increased FDG accumulation in the thymus was observed in any of the group IIa patients. In cases of visible FDG uptake in the thymus, standardized uptake values did not exceed 4. Conclusion: FDG accumulation in the thymus is a common finding in children and can occasionally be observed in young adults after chemotherapy. Knowledge of the characteristics of a typical retrosternal lesion in conjunction with the clinical history allows avoidance of diagnostic uncertainty and unnecessary procedures.

Key Words: thymus hyperplasia • FDG PET • chemotherapy

This article has been cited by other articles:

				A. Shammas, R. Lim, and M. Charron Pediatric FDG PET/CT: Physiologic Uptake, Normal Variants, and Benign Conditions RadioGraphics, September 1, 2009; 29(5): 1467 - 1486. [Abstract] [Full Text] [PDF]

				J. Jerushalmi, A. Frenkel, R. Bar-Shalom, J. Khoury, and O. Israel Physiologic Thymic Uptake of 18F-FDG in Children and Young Adults: A PET/CT Evaluation of Incidence, Patterns, and Relationship to Treatment J. Nucl. Med., June 1, 2009; 50(6): 849 - 853. [Abstract] [Full Text] [PDF]

				P. Seam, M. E. Juweid, and B. D. Cheson The role of FDG-PET scans in patients with lymphoma Blood, November 15, 2007; 110(10): 3507 - 3516. [Abstract] [Full Text] [PDF]

				C. S. Smith, H. Schoder, and H. W. D. Yeung Thymic Extension in the Superior Mediastinum in Patients with Thymic Hyperplasia: Potential Cause of False-Positive Findings on 18F-FDG PET/CT Am. J. Roentgenol., June 1, 2007; 188(6): 1716 - 1721. [Abstract] [Full Text] [PDF]

				T. Inaoka, K. Takahashi, M. Mineta, T. Yamada, N. Shuke, A. Okizaki, K. Nagasawa, H. Sugimori, and T. Aburano Thymic Hyperplasia and Thymus Gland Tumors: Differentiation with Chemical Shift MR Imaging Radiology, June 1, 2007; 243(3): 869 - 876. [Abstract] [Full Text] [PDF]

				K Strobel, N. Schaefer, C Renner, P Veit-Haibach, D Husarik, A. Koma, and T. Hany Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients? Ann. Onc., April 1, 2007; 18(4): 658 - 664. [Abstract] [Full Text] [PDF]

				T. Bunyaviroch and R. E. Coleman PET Evaluation of Lung Cancer J. Nucl. Med., March 1, 2006; 47(3): 451 - 469. [Full Text] [PDF]

				B. Ferdinand, P. Gupta, and E. L. Kramer Spectrum of Thymic Uptake at 18F-FDG PET RadioGraphics, November 1, 2004; 24(6): 1611 - 1616. [Abstract] [Full Text] [PDF]

				R. M. Meyer, R. F. Ambinder, and S. Stroobants Hodgkin's Lymphoma: Evolving Concepts with Implications for Practice Hematology, January 1, 2004; 2004(1): 184 - 202. [Abstract] [Full Text] [PDF]

				K. Takahashi, T. Inaoka, N. Murakami, H. Hirota, K. Iwata, K. Nagasawa, T. Yamada, M. Mineta, and T. Aburano Characterization of the Normal and Hyperplastic Thymus on Chemical-Shift MR Imaging Am. J. Roentgenol., May 1, 2003; 180(5): 1265 - 1269. [Abstract] [Full Text] [PDF]

				C. Wittram, A. J. Fischman, E. Mark, J. Ko, and J.-A. O. Shepard Thymic Enlargement and FDG Uptake in Three Patients: CT and FDG Positron Emission Tomography Correlated with Pathology Am. J. Roentgenol., February 1, 2003; 180(2): 519 - 522. [Abstract] [Full Text] [PDF]

				S. A. Nehmeh, Y. E. Erdi, C. C. Ling, K. E. Rosenzweig, H. Schoder, S. M. Larson, H. A. Macapinlac, O. D. Squire, and J. L. Humm Effect of Respiratory Gating on Quantifying PET Images of Lung Cancer J. Nucl. Med., July 1, 2002; 43(7): 876 - 881. [Abstract] [Full Text] [PDF]

				T Nakahara, H Fujii, M Ide, N Nishiumi, W Takahashi, S Yasuda, A Shohtsu, and A Kubo FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography andCT Br. J. Radiol., September 1, 2001; 74(885): 821 - 824. [Abstract] [Full Text] [PDF]